2005
DOI: 10.3892/ijmm.16.2.263
|View full text |Cite
|
Sign up to set email alerts
|

Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: An immunohistochemical study of 86 cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
24
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(24 citation statements)
references
References 0 publications
0
24
0
Order By: Relevance
“…In cancers of the head and neck including oral cancer, there are some reports that SPARC expression correlates with poor prognosis [24,25]. However, in invasive oral squamous cell carcinoma (OSCC) specimen, immunohistochemical expression of SPARC was not correlated with survival rate and clinicopathological conditions such as T stage, clinical type, differentiation, and lymph node metastasis.…”
Section: Discussionmentioning
confidence: 98%
“…In cancers of the head and neck including oral cancer, there are some reports that SPARC expression correlates with poor prognosis [24,25]. However, in invasive oral squamous cell carcinoma (OSCC) specimen, immunohistochemical expression of SPARC was not correlated with survival rate and clinicopathological conditions such as T stage, clinical type, differentiation, and lymph node metastasis.…”
Section: Discussionmentioning
confidence: 98%
“…Not surprisingly, many cancers exhibit altered SPARC expression. Several cancers including glioma, melanoma, tongue and oral, head and neck, esophageal, and breast show an increased level of SPARC, relative to that of their respective normal tissue, which correlates positively with invasion and metastasis (Chin et al, 2005;Choi et al, 2008;Framson and Sage, 2004;Kato et al, 2005;Xue et al, 2006). Conversely, loss of SPARC in colorectal cancer is correlated with a worse prognosis (Cheetham et al, 2008;Yang et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…PLAU has been suggested to be implicated in enhanced cell proliferation and migration (41) and as a prognostic marker for relapse-free survival of OSCCs, together with its receptor uPAR (42). SPARC, or osteonectin, is also implicated in ECM breakdown (43) and has been reported to be associated with tumor progression and metastasis (44). This protein was previously reported in two studies from Sudan, where the use of oral snuff (toombak) is common (45,46).…”
Section: Discussionmentioning
confidence: 99%